Glaxo still touting Darapladib today on conference call
This year, Glaxo will announce the long-awaited results of one of their phase III trials. Anything good on that front will surely catapult Diadexus. If Darapladib is the "next" lipitor, how will patients know whether they have high levels of LP-PLa2? They will need the Plac test. Who started the question, "have you had your cholesterol checked?" Well, I am officially patenting the question, "have you had your PLac checked."
You see benlystas number last quarter? 43 million. After 2 years and the mighty Glaxo marketing arm, 43 million. Sales are now peak. The only blockbuster that came out of that company was your lawn mower. Thanks for tracking me down here. In 2 years, Benlysta will be sold,by Glaxo, it's worthless.